Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

AIDS Threat From Breastfeeding Declines With Treatment in Study

June 24, 2010

HIV-positive mothers who receive antiretroviral therapy are likely to be able to breastfeed their newborns without passing on the virus, suggest the findings of two recent reports.

In a study from Botswana, 560 HIV 1-positive women who were randomized to three different regimens of highly active antiretroviral therapy administered from pregnancy through six-months postpartum had a combined rate of mother-to-child transmission of 1.1 percent. Women were randomized to a nucleoside reverse-transcriptase inhibitor group, a protease inhibitor group or an observational group that received nevirapine plus zidovudine-lamivudine.

All infants received single dose nevirapine and four weeks of zidovudine.

Advertisement
The authors described the transmission rates among the groups as similar, but noted that the study was not designed to compare rates among the groups.

In a separate study of 2,369 HIV 1-positive breastfeeding women in Malawi, researchers compared the efficacy of a maternal antiretroviral program and infant nevirapine in reducing HIV transmission. A control group received no extended postnatal antiretroviral regime.

Among the mother-infant pairs, 5.0 percent of infants were HIV-positive two weeks after birth. The risk of HIV transmission between week 2 and week 28 was 5.7 percent in the control group, 2.9 percent in the maternal regimen group (P=0.009) and 1.7 percent in the infant regimen group (P<0.001). The authors concluded that either a maternal antiretroviral regimen or infant nevirapine for 28 weeks was effective for reducing HIV transmission during breastfeeding.

"Health care providers and mothers can ultimately choose the option that best suits their cultural, economic, and individual needs, since there is now evidence for two effective options to prevent the transmission of HIV-1 to infants from their mothers during breast-feeding in resource-limited countries," the authors concluded.

The full reports, "Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana" and "Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission," were published in the New England Journal of Medicine (2010; 364(24):2282-2294 and 2271-2281).

Back to other news for June 2010

Adapted from:
Bloomberg News
06.16.2010; Tom Randall


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Breastfeeding & HIV/AIDS

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement